[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
Publication Ethics::
Peer Review Process::
Indexing Databases::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
::
Google Scholar Metrics

Citation Indices from GS

AllSince 2019
Citations64463744
h-index2720
i10-index18983

..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Registered in

AWT IMAGE

AWT IMAGE

..
:: Volume 32, Issue 1 (4-2024) ::
Journal of Ilam University of Medical Sciences 2024, 32(1): 75-82 Back to browse issues page
Comparison of the frequency of HHV-8 virus in patients with systemic lupus erythematosus and healthy population
Javad Moayedi1 , Zahra Mousavi1 , Ava Hashempour * 2, Mohammad Ali Nazarinia3
1- Clinical Microbiology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran
2- Clinical Microbiology Research Center, Nemazee Hospital, Shiraz University of Medical Sciences, Shiraz, Iran , ava.hashempour1979@gmail.com
3- Shiraz Geriatric Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
Abstract:   (175 Views)
Introduction:  Lupus is a chronic systemic disorder with a complex etiology, and viral infections have contributed to its development and progression. Human herpesvirus-8 (HHV-8) has been diagnosed in many patients with autoimmune disorders; however, its role in lupus has not been well investigated. The present study aimed to compare the frequency and viral load of HHV-8 in patients with lupus and healthy population.
Material & Methods: In this cross-sectional study, 70 patients with lupus and 70 healthy individuals who were matched for gender and age were included. After the extraction of viral DNA, the HHV-8 viral load was measured using the Real-time polymerase chain reaction (PCR) technique, and the results were analyzed by SPSS software.
Results: Patients with lupus consisted of 59 females (84.3%) and 11 males (15.7%) with a mean age of 31.1±8.4 years, and the control group consisted of 58 females (82.9%) and 12 males (17.1%) with a mean age of 33.5±11.2 years, none of them were positive for HHV-8 genome.
Discussion & Conclusion: To date, there is no report in this field from Iran, and this study is the first survey. Regarding the high accuracy of the Real-time PCR technique and lack of HHV-8 genome in the blood samples of Iranian patients with lupus, it seems that none of the individuals, even in the case of viral infection, were infected with the active form of HHV-8, which is compatible with the previous studies.
Keywords: HHV-8, Lupus, Real-time PCR, Viral load
Full-Text [PDF 441 kb]   (102 Downloads)    
Type of Study: Research | Subject: infectious diseases
Received: 2023/06/16 | Accepted: 2023/11/7 | Published: 2024/05/4
References
1. Lazar S, Kahlenberg JM. Systemic lupus erythematosus: new diagnostic and therapeutic approaches. Annu Rev Med 2023; 74:339-52. doi: 10.1146/annurev-med-043021-032611.
2. Sayiner ZA, Haque U, Malik MU, Gurakar A. Hepatitis C virus infection and its rheumatologic implications. Gastroenterol Hepatol 2014; 10:287-93.
3. Fatoye F, Gebrye T, Mbada C. Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis. Rheumatol Int 2022; 42:2097-107. doi: 10.1007/s00296-022-05183-4.
4. Agmon-Levin N, Mosca M, Petri M, Shoenfeld Y. Systemic lupus erythematosus one disease or many? Autoimmun Rev 2012; 11:593-5. doi: 10.1016/j.autrev.2011.10.020.
5. Tobón GJ, Izquierdo JH, Cañas CA. B lymphocytes: development, tolerance, and their role in autoimmunity—focus on systemic lupus erythematosus. Autoimmune Dis 2013; 2013:827254. doi: 10.1155/2013/827254.
6. Namazi S, Ziaee V, Rezaei N. The role of cytokines in systemic lupus erythematosis. Tehran Univ Med J 2015; 73:397-404.
7. Gómez-Bañuelos E, Fava A, Andrade F. An update on autoantibodies in systemic lupus erythematosus. Curr Opin Rheumatol 2023; 35:61-67. doi: 10.1097/BOR.0000000000000922.
8. Cojocaru M, Cojocaru IM, Silosi I, Vrabie CD. Manifestations of systemic lupus erythematosus. Maedica 2011; 6:330-36.
9. Touma Z, Hoskin B, Atkinson C, Bell D, Massey O, Lofland JH, et al. Systemic lupus erythematosus symptom clusters and their association with Patient‐Reported outcomes and treatment: analysis of Real‐World data. Arthritis Care Res 2022; 74:1079-88. doi: 10.1002/acr.24546.
10. Hasan B, Fike A, Hasni S. Health disparities in systemic lupus erythematosus—a narrative review. Clin Rheumatol 2022; 41:3299-311. doi: 10.1007/s10067-022-06268-y.
11. Jung JY, Suh CH. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. Korean J Intern Med 2017; 32:429-38. doi: 10.3904/kjim.2016.234.
12. Deng Y, Tsao BP. Genetic susceptibility to systemic lupus erythematosus in the genomic era. Nat Rev Rheumatol 2010; 6:683-92. doi: 10.1038/nrrheum.2010.176.
13. Nelson P, Rylance P, Roden D, Trela M, Tugnet N. Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus 2014; 23:596-605. doi: 10.1177/0961203314531637.
14. Stack G, Stacey MA, Humphreys IR. Herpesvirus exploitation of host immune inhibitory pathways. Viruses 2012; 4:1182-201. doi: 10.3390/v4081182.
15. Rohner E, Wyss N, Trelle S, Mbulaiteye SM, Egger M, Novak U, et al. HHV-8 seroprevalence: a global view. Syst Rev 2014; 3:1-7. doi: 10.1186/2046-4053-3-11.
16. Iwata S, Tanaka Y. Association of viral infection with the development and pathogenesis of systemic lupus erythematosus. Front Med 2022; 9:849120. doi: 10.3389/fmed.2022.849120.
17. Balada E, Ramentol M, Felip L, Ordi-Ros J, Selva-O’Callaghan A, Simeón-Aznar C, et al. Prevalence of HHV-8 in systemic autoimmune diseases. J Clin Virol 2015; 62:84-88. doi: 10.1016/j.jcv.2014.11.022.
18. Tung YC, Ke LY, Tsai SM, Lu PL, Tsai WC. High seroprevalence of human herpesvirus 8 infection in patients with systemic lupus erythematosus. Int J Rheum Dis 2013; 16:709-14. doi: 10.1111/1756-185X.12193.
19. Sun Y, Sun S, Li W, Li B, Li J. Prevalence of human herpesvirus 8 infection in systemic lupus erythematosus. Virol J 2011; 8:1-5. doi: 10.1186/1743-422X-8-210.
20. Jalilvand S, Shoja Z, Mokhtari-Azad T, Nategh R, Gharehbaghian A. Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran. Infect Agent Cancer 2011; 6:1-6. doi: 10.1186/1750-9378-6-5.
21. Siddiqui F, Al Ameer MA, Al-Khalaf J, Al-Marzooq Y, Al Ameer A, Al Ameer M. Human Herpesvirus 8 (HHV-8) Staining: A Savior in Early Kaposi Sarcoma. Cureus 2023;15: e36486. doi: 10.7759/cureus.36486.
22. Elkon KB, Wiedeman A. Type I IFN system in the development and manifestations of SLE. Curr Opin Rheumatol 2012; 24:499-505. doi: 10.1097/BOR.0b013e3283562c3e.
23. Caielli S, Wan Z, Pascual V. Systemic lupus erythematosus pathogenesis: interferon and beyond. Annu Rev Immunol 2023; 41:533-60. doi: 10.1146/annurev-immunol-101921-042422.
24. Davatchi F, Jamshidi A-R, Banihashemi AT, Gholami J, Forouzanfar MH, Akhlaghi M, et al. WHO-ILAR COPCORD study (stage 1, urban study) in Iran. J Rheumatol 2008; 35:1384-90.
25. Broccolo F, Drago F, Cassina G, Fava A, Fusetti L, Matteoli B, et al. Selective reactivation of human herpesvirus 6 in patients with autoimmune connective tissue diseases. J Med Virol 2013; 85:1925-34. doi: 10.1002/jmv.23670.
26. Hashempour A, Moayedi J, Musavi Z, Ghasabi F, Halaji M, Hasanshahi Z, et al. First report of HHV-8 viral load and seroprevalence of major blood-borne viruses in Iranian patients with systemic sclerosis. Mult Scler Relat Disord 2021; 51:102872. doi: 10.1016/j.msard.2021.102872.
27. Wang X, He B, Zhang Z, Liu T, Wang H, Li X, et al. Human herpesvirus-8 in northwestern China: epidemiology and characterization among blood donors. Virology J 2010; 7:1-7. doi: 10.1186/1743-422X-7-62.
28. Reis ADd, Mudinutti C, Peigo MdF, Leon LL, Costallat LTL, Rossi CL, et al. Active human herpesvirus infections in adults with systemic lupus erythematosus and correlation with the SLEDAI score. Adv Rheumatol 2020; 60:47-53. doi: 10.1186/s42358-020-00144-6.
29. Chou A, Huang W, Lin M, Su C. Human herpesvirus type 8 in patients with cirrhosis independent of thrombocytopenia. J Clin Pathol 2010; 63:254-58. doi: 10.1136/jcp.2009.071621.
30. Marcelin AG, Motol J, Guihot A, Caumes E, Viard JP, Dussaix E, et al. Relationship between the Quantity of Kaposi Sarcoma—Associated Herpesvirus (KSHV) in Peripheral Blood and Effusion Fluid Samples and KSHV-Associated Disease. J Infect Dis 2007; 196:1163-66. doi: 10.1086/521625.
31. Sergerie Y, Abed Y, Roy J, Boivin G. Comparative evaluation of three serological methods for detection of human herpesvirus 8-specific antibodies in Canadian allogeneic stem cell transplant recipients. J Clin Microbiol 2004; 42:2663-67. doi: 10.1128/jcm.42.6.2663-2667.2004.
32. Tedeschi R, Bidoli E, Agren Å, Hallmans G, Wadell G, De Paoli P, et al. Epidemiology of Kaposi's Sarcoma herpesvirus (HHV8) in Västerbotten county, Sweden. J Med Virol 2006; 78:372-78. doi: 10.1002/jmv.20549.
33. Hudnall SD, Chen T, Allison P, Tyring SK, Heath A. Herpesvirus prevalence and viral load in healthy blood donors by quantitative real‐time polymerase chain reaction. Transfusion 2008; 48:1180-7. doi: 10.1111/j.1537-2995.2008.01685. x.
34. Spira TJ, Lam L, Dollard SC, Meng YX, Pau CP, Black JB, et al. Comparison of serologic assays and PCR for diagnosis of human herpesvirus 8 infection. J Clin Microbiol 2000; 38:2174-80. doi:10.1128/jcm.38.6.2174-2180.2000.
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA

Ethics code: IR.SUMS.REC.1397.771


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Moayedi J, Mousavi Z, Hashempour A, Nazarinia M A. Comparison of the frequency of HHV-8 virus in patients with systemic lupus erythematosus and healthy population. J. Ilam Uni. Med. Sci. 2024; 32 (1) :75-82
URL: http://sjimu.medilam.ac.ir/article-1-8008-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 32, Issue 1 (4-2024) Back to browse issues page
مجله دانشگاه علوم پزشکی ایلام Journal of Ilam University of Medical Sciences
Persian site map - English site map - Created in 0.16 seconds with 41 queries by YEKTAWEB 4654